Goodwin Impact

A Big Deal in BioTech

In one of the largest Series A financing deals for a biotech startup, Goodwin advised Versant Ventures in its deal with global life science company Bayer AG to create BlueRock Therapeutics, a company working to develop life-saving, next-generation regenerative medicines.
View Case Study

Winning When It Counts

Goodwin successfully represented Alkermes when it faced a legal challenge from a competitor over the launch of ARISTADA, an innovative injectable long-acting drug used for the treatment of schizophrenia.

View Case Study

Fighting for What's Right

When several cities in the United States passed ordinances banning the homeless from asking passersby for charity, dozens of Goodwin attorneys teamed with the ACL U to challenge the bans on First Amendment grounds.

View Case Study

Welcome Home

Goodwin represented the underwriters in the $1.8 billion initial public offering of Invitation Homes, the second-largest REIT IPO ever, behind Goodwin client Paramount Group’s REIT IPO in 2014.
View Case Study

Even Better Together

In one of France’s largest-ever growth equity capital rounds, Goodwin advised KKR & Co. LP on its $70 million investment in Ivalua, a software company based in Paris and Silicon Valley.

View Case Study
View All Case Studies
Client Value


No two clients share the exact same vision or challenges. So we don't have a one-size-fits-all approach to client service. At Goodwin, we take the time to understand your business and adapt ours to yours.
See what it means for you
Explore Goodwin
Explore By Interest
Contact By Office